This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating ...

A study from Columbia University Mailman School of Public Health reports a major advance in understanding how interactions ...

Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today ...

Clinical genome sequencing now delivers genetic diagnoses for about 1 in 4 suspected rare disease patients, guiding targeted ...

To many, the genome is a puzzle—a many-sided puzzle whose meaning stretches across your life, your children's, and your family's. To many, the genome is a puzzle—a many-sided puzzle whose meaning ...

A team of researchers spent years watching their quantum circuits fail before one finally worked. In early 2025, scientists ...

Researchers at the University of Zurich have analyzed the genome of bacteria living in Lake Zurich to conclude that microbes ...

EPFL scientists have discovered that a simple shape change in mitochondria helps cells evenly distribute their mitochondrial ...

The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations have limited advancement of the field. While existing editing ...

Explore the decades-long journey to map the full human genome, from early breakthroughs to the first complete, gapless DNA ...

A research team has uncovered the genomic basis behind why some vine tea varieties accumulate far more dihydromyricetin than others.